148 related articles for article (PubMed ID: 38905570)
1. Breast Cancer Brain Metastases: Challenges and Opportunities.
Peereboom DM
JCO Oncol Pract; 2024 Jun; ():OP2400353. PubMed ID: 38905570
[No Abstract] [Full Text] [Related]
2. Therapy of breast cancer brain metastases: challenges, emerging treatments and perspectives.
Kotecki N; Lefranc F; Devriendt D; Awada A
Ther Adv Med Oncol; 2018; 10():1758835918780312. PubMed ID: 29977353
[TBL] [Abstract][Full Text] [Related]
3. Challenges in the treatment of breast cancer brain metastases: evidence, unresolved questions, and a practical algorithm.
Meattini I; Andratschke N; Kirby AM; Sviri G; Offersen BV; Poortmans P; Kaidar Person O
Clin Transl Oncol; 2020 Oct; 22(10):1698-1709. PubMed ID: 32207041
[TBL] [Abstract][Full Text] [Related]
4. Challenges in the treatment of hormone receptor-positive, HER2-negative metastatic breast cancer with brain metastases.
Liu MC; Cortés J; O'Shaughnessy J
Cancer Metastasis Rev; 2016 Jun; 35(2):323-32. PubMed ID: 27023712
[TBL] [Abstract][Full Text] [Related]
5. New challenges and opportunities in the management of brain metastases in patients with ErbB2-positive metastatic breast cancer.
Melisko ME; Glantz M; Rugo HS
Nat Clin Pract Oncol; 2009 Jan; 6(1):25-33. PubMed ID: 18936791
[TBL] [Abstract][Full Text] [Related]
6. Molecular subtyping of brain metastases and implications for therapy.
Renfrow JJ; Lesser GJ
Curr Treat Options Oncol; 2013 Dec; 14(4):514-27. PubMed ID: 23907440
[TBL] [Abstract][Full Text] [Related]
7. Brain metastases in HER2-positive breast cancer: challenges and opportunities.
Torrejón D; Di Cosimo S
Ann Palliat Med; 2012 Oct; 1(3):195-7. PubMed ID: 25841511
[No Abstract] [Full Text] [Related]
8. Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
Drugs R D; 2005; 6(3):178-85. PubMed ID: 15869322
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Factors and Survival Outcomes among Patients with Breast Cancer and Brain Metastases at Diagnosis: A National Cancer Database Analysis.
Zimmerman BS; Seidman D; Cascetta KP; Ru M; Moshier E; Tiersten A
Oncology; 2021; 99(5):280-291. PubMed ID: 33652435
[TBL] [Abstract][Full Text] [Related]
10. B7-H3 Expression in Breast Cancer and Brain Metastasis.
Joshi V; Beecher K; Lim M; Stacey A; Feng Y; Jat PS; Duijf PHG; Simpson PT; Lakhani SR; McCart Reed AE
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612786
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of drug resistance in breast cancer liver metastases: Dilemmas and opportunities.
Yan CY; Zhao ML; Wei YN; Zhao XH
Mol Ther Oncolytics; 2023 Mar; 28():212-229. PubMed ID: 36860815
[TBL] [Abstract][Full Text] [Related]
12. Changes in BAI1 and nestin expression are prognostic indicators for survival and metastases in breast cancer and provide opportunities for dual targeted therapies.
Meisen WH; Dubin S; Sizemore ST; Mathsyaraja H; Thies K; Lehman NL; Boyer P; Jaime-Ramirez AC; Elder JB; Powell K; Chakravarti A; Ostrowski MC; Kaur B
Mol Cancer Ther; 2015 Jan; 14(1):307-14. PubMed ID: 25376607
[TBL] [Abstract][Full Text] [Related]
13. Cerebellar preference of luminal A and B type and basal ganglial preference of HER2-positive type breast cancer-derived brain metastases.
Izutsu N; Kinoshita M; Ozaki T; Sakai M; Nakanishi K; Nakayama T; Tamaki Y; Kishima H
Mol Clin Oncol; 2021 Sep; 15(3):175. PubMed ID: 34276994
[TBL] [Abstract][Full Text] [Related]
14. Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden.
Frisk G; Svensson T; Bäcklund LM; Lidbrink E; Blomqvist P; Smedby KE
Br J Cancer; 2012 May; 106(11):1850-3. PubMed ID: 22531629
[TBL] [Abstract][Full Text] [Related]
15. A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina Experience.
McKee MJ; Keith K; Deal AM; Garrett AL; Wheless AA; Green RL; Benbow JM; Dees EC; Carey LA; Ewend MG; Anders CK; Zagar TM
Oncologist; 2016 Jan; 21(1):16-20. PubMed ID: 26659221
[TBL] [Abstract][Full Text] [Related]
16. Intracranial Response Rate in Patients with Breast Cancer Brain Metastases after Systemic Therapy.
Niwinska A; Pogoda K; Jagiello-Gruszfeld A; Duchnowska R
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205723
[TBL] [Abstract][Full Text] [Related]
17. Characterization of passive permeability at the blood-tumor barrier in five preclinical models of brain metastases of breast cancer.
Adkins CE; Mohammad AS; Terrell-Hall TB; Dolan EL; Shah N; Sechrest E; Griffith J; Lockman PR
Clin Exp Metastasis; 2016 Apr; 33(4):373-83. PubMed ID: 26944053
[TBL] [Abstract][Full Text] [Related]
18. Genomic landscape of the immune microenvironments of brain metastases in breast cancer.
Lu WC; Xie H; Yuan C; Li JJ; Li ZY; Wu AH
J Transl Med; 2020 Aug; 18(1):327. PubMed ID: 32867782
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome of brain metastases differs significantly among breast cancer subtypes.
Oehrlich NE; Spineli LM; Papendorf F; Park-Simon TW
Oncol Lett; 2017 Jul; 14(1):194-200. PubMed ID: 28693153
[TBL] [Abstract][Full Text] [Related]
20. Brain metastases in breast cancer.
Niikura N; Saji S; Tokuda Y; Iwata H
Jpn J Clin Oncol; 2014 Dec; 44(12):1133-40. PubMed ID: 25320339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
